GLOBAL CANCER TECHNOLOGY, INC. — Federal Contracts, Awards & Government Contractor Profile

About GLOBAL CANCER TECHNOLOGY, INC.

Global Cancer Technology is a non-revenue biopharma company developing a novel small molecule PI3K inhibitor, GCT-007, designed to cross the blood-brain barrier and treat glioblastoma. The company aims to significantly impact cancer treatment outcomes through its unique radioactivated drug transport technology.

Development of a novel small molecule PI3K inhibitor (GCT-007) that crosses the blood-brain barrierPreclinical trials for an anti-cancer inhibitor with promising results in arresting tumor growth in micePatent portfolio covering GCT-007, GCT-008, and combinations with checkpoint inhibitorsResearch and development of dual inhibitors targeting the PI3K and mTOR pathways

Is this your company?

Claim GLOBAL CANCER TECHNOLOGY, INC. to unlock the federal & state contracts GovIntel's AI has matched to you right now — plus your own scored past-performance, who you're up against, and who's risky to team with.

Claim GLOBAL CANCER TECHNOLOGY, INC. & see your matches

Free to claim. Takes about a minute.

Data compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate, or want this page removed? Request a correction or removal.